Invention Grant
- Patent Title: Heterocyclic kinase inhibitors
-
Application No.: US15500116Application Date: 2015-07-27
-
Publication No.: US10035777B2Publication Date: 2018-07-31
- Inventor: Carolyn Diane Dzierba , Joanne J. Bronson , John E. Macor , Bireshwar Dasgupta , Susheel Jethanand Nara , Vivekananda M. Vrudhula , Senliang Pan , Richard A. Hartz , Ramkumar Rajamani
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- International Application: PCT/US2015/042165 WO 20150727
- International Announcement: WO2016/022312 WO 20160211
- Main IPC: C07D235/14
- IPC: C07D235/14 ; C07D401/04 ; C07D403/04 ; C07D413/04 ; C07D417/04 ; C07D471/04 ; C07D487/04 ; C07D401/14
Abstract:
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
Public/Granted literature
- US20170260145A1 HETEROCYCLIC KINASE INHIBITORS Public/Granted day:2017-09-14
Information query
